FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

VERIGENE STAPHYLOCOCCUS BLOOD CULTURE NUCLEIC ACID TEST (BC-S)

K Number: K112424 · Decision Dec 16, 2011
Classifications
1
FEI Numbers
11
Registration Numbers
11
Same Product Code
23
Applicant Total
16
Review Days
115

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
VERIGENE STAPHYLOCOCCUS BLOOD CULTURE NUCLEIC ACID TEST (BC-S)
K Number
K112424
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.1640
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Nanosphere, Inc.
Date Received
August 23, 2011
Decision Date
December 16, 2011
Product Code
NQX
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NQX System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (NQX), ordered by most recent decision date.

View all

Other Clearances by Nanosphere, Inc.

K Number Device Name
K143653 Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex)
K140083 VERIGENE ENTERIC PATHOGEN NUCLEIC ACID TEST ( EP)
K132843 VERIGENE GRAM NEGATIVE BLOOD CULTURE NUCLEIC ACID TEST (BC-GN)
K123197 VERIGENE C. DIFFICILE NUCLEIC ACID TEST (CDF)
K120466 VERIGENE CYP2C19 NUCLEIC ACID TES (2C19)
K122514 VERIGENE GRAM-POSITIVE BLOOD CULTURE (GC-GP) NUCLEIC ACID TEST
DEN120014 VERIGENE GRAM POSITIVE BLOOD CULTURE NUCLEIC ACID TEST (BC-GP)
K103209 VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST +(RVNAT+)
K093337 VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST ON THE VERIGENE SP SYSTEM
K092957 VERIGENE SYSTEM, VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST
Search all 16 clearances from Nanosphere, Inc. →